New urine test could spot deadly pancreatic cancer sooner
NCT ID NCT04449406
Summary
This study aims to develop a better test to catch pancreatic cancer early. Researchers are collecting urine and blood samples from 3,500 people who have symptoms or are at risk for the disease. They will analyze these samples to see if a new combination of markers can accurately diagnose cancer before it spreads.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ADEPTS study, University College London
ACTIVE_NOT_RECRUITINGLondon, United Kingdom
-
EUROPAC study, University of Liverpool
ACTIVE_NOT_RECRUITINGLiverpool, United Kingdom
-
Imperial College London
ACTIVE_NOT_RECRUITINGLondon, United Kingdom
-
Royal London Hospital
RECRUITINGLondon, United Kingdom
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.